Abstract

Influenza activity* in the United States during the 2018-19 season (September 30, 2018-May 18, 2019) was of moderate severity (1). Nationally, influenza-like illness (ILI)† activity began increasing in November, peaked during mid-February, and returned to below baseline in mid-April; the season lasted 21 weeks,§ making it the longest season in 10 years. Illness attributed to influenza A viruses predominated, with very little influenza B activity. Two waves of influenza A were notable during this extended season: influenza A(H1N1)pdm09 viruses from October 2018 to mid-February 2019 and influenza A(H3N2) viruses from February through May 2019. Compared with the 2017-18 influenza season, rates of hospitalization this season were lower for adults, but were similar for children. Although influenza activity is currently below surveillance baselines, testing for seasonal influenza viruses and monitoring for novel influenza A virus infections should continue year-round. Receiving a seasonal influenza vaccine each year remains the best way to protect against seasonal influenza and its potentially severe consequences.

Highlights

  • Receiving a seasonal influenza vaccine each year remains the best way to protect against seasonal influenza and its potentially severe consequences

  • Seasonal influenza activity is currently below baseline, influenza illnesses are often reported during the summer

  • Treatment as soon as possible with influenza antiviral medications is recommended for patients with confirmed or suspected influenza who have severe, complicated, or progressive illness; who require hospitalization; or who are at high risk for influenza-associated complications [8]

Read more

Summary

Morbidity and Mortality Weekly Report

Update: Influenza Activity in the United States During the 2018–19 Season and Composition of the 2019–20 Influenza Vaccine. Xiyan Xu, MD1; Lenee Blanton, MPH1; Anwar Isa Abd Elal; Noreen Alabi, MPH1; John Barnes, PhD1; Matthew Biggerstaff, ScD1; Lynnette Brammer, MPH1; Alicia P. Influenza activity* in the United States during the 2018–19 season (September 30, 2018–May 18, 2019) was of moderate severity [1]. Influenza-like illness (ILI)† activity began increasing in November, peaked during mid-February, and returned to below baseline in mid-April; the season lasted 21 weeks,§ making it the longest season in 10 years. Influenza activity is currently below surveillance baselines, testing for seasonal influenza viruses and monitoring for novel influenza A virus infections should continue year-round. Receiving a seasonal influenza vaccine each year remains the best way to protect against seasonal influenza and its potentially severe consequences

Virus Surveillance
No of positive specimens
Antigenic and Genetic Characterization of Influenza Viruses
Antiviral Susceptibility of Influenza Viruses
Outpatient Illness Surveillance
Geographic Spread of Influenza Activity
National baseline
Severity Assessment
Preliminary Estimates of Influenza Burden
Discussion
What is added by this report?
What are the implications for public health practice?

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.